⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRKR News
Marker Therapeutics, Inc. Common Stock
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
globenewswire.com
MRKR
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
globenewswire.com
MRKR
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
globenewswire.com
MRKR
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
globenewswire.com
MRKR
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program
globenewswire.com
MRKR